A research team at Leibniz-HKI has described a new enzyme that renders the highly toxic molecule malleicyprol harmless. Malleicyprol is considered an important virulence factor of Burkholderia bacteria, which causes, among other things, the dangerous tropical disease melioidosis. The discovery opens up new avenues for strategies against antibiotic-resistant pathogens.